114 related articles for article (PubMed ID: 11086731)
1. Arylacetamides as peripherally restricted kappa opioid receptor agonists.
Kumar V; Marella MA; Cortes-Burgos L; Chang AC; Cassel JA; Daubert JD; DeHaven RN; DeHaven-Hudkins DL; Gottshall SL; Mansson E; Maycock AL
Bioorg Med Chem Lett; 2000 Nov; 10(22):2567-70. PubMed ID: 11086731
[TBL] [Abstract][Full Text] [Related]
2. The peripherally acting kappa-opiate agonist EMD 61753 and analogues: opioid activity versus peripheral selectivity.
Gottschlich R; Barber A; Bartoszyk GD; Seyfried CA
Drugs Exp Clin Res; 1995; 21(5):171-4. PubMed ID: 8846746
[TBL] [Abstract][Full Text] [Related]
3. A pharmacological profile of the novel, peripherally-selective kappa-opioid receptor agonist, EMD 61753.
Barber A; Bartoszyk GD; Bender HM; Gottschlich R; Greiner HE; Harting J; Mauler F; Minck KO; Murray RD; Simon M
Br J Pharmacol; 1994 Dec; 113(4):1317-27. PubMed ID: 7889287
[TBL] [Abstract][Full Text] [Related]
4. Novel phenylamino acetamide derivatives as potent and selective kappa opioid receptor agonists.
Chu GH; Gu M; Cassel JA; Belanger S; Stabley GJ; DeHaven RN; Conway-James N; Koblish M; Little PJ; DeHaven-Hudkins DL; Dolle RE
Bioorg Med Chem Lett; 2006 Feb; 16(3):645-8. PubMed ID: 16263278
[TBL] [Abstract][Full Text] [Related]
5. Effect of the peripherally selective kappa-opioid agonist, asimadoline, on adjuvant arthritis.
Binder W; Walker JS
Br J Pharmacol; 1998 Jun; 124(4):647-54. PubMed ID: 9690855
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and pharmacological evaluation of 5-pyrrolidinylquinoxalines as a novel class of peripherally restricted κ-opioid receptor agonists.
Bourgeois C; Werfel E; Galla F; Lehmkuhl K; Torres-Gómez H; Schepmann D; Kögel B; Christoph T; Straßburger W; Englberger W; Soeberdt M; Hüwel S; Galla HJ; Wünsch B
J Med Chem; 2014 Aug; 57(15):6845-60. PubMed ID: 25062506
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of novel peripherally restricted kappa-opioid receptor agonists.
Kumar V; Guo D; Cassel JA; Daubert JD; Dehaven RN; Dehaven-Hudkins DL; Gauntner EK; Gottshall SL; Greiner SL; Koblish M; Little PJ; Mansson E; Maycock AL
Bioorg Med Chem Lett; 2005 Feb; 15(4):1091-5. PubMed ID: 15686919
[TBL] [Abstract][Full Text] [Related]
8. kappa-Opioid activity of the four stereoisomers of the peripherally selective kappa-agonists, EMD 60,400 and EMD 61,753.
Gottschlich R; Krug M; Barber A; Devant RM
Chirality; 1994; 6(8):685-9. PubMed ID: 7857777
[TBL] [Abstract][Full Text] [Related]
9. 3-Pyrroline containing arylacetamides: a novel series of remarkably selective kappa-agonists.
Mou QY; Chen J; Zhu YC; Zhou DH; Chi ZQ; Long YQ
Bioorg Med Chem Lett; 2002 Sep; 12(17):2287-90. PubMed ID: 12161117
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the antinociceptive effects of TRK-820 in the rat.
Endoh T; Tajima A; Suzuki T; Kamei J; Narita M; Tseng L; Nagase H
Eur J Pharmacol; 2000 Jan; 387(2):133-40. PubMed ID: 10650153
[TBL] [Abstract][Full Text] [Related]
11. Peripheral effects of the kappa-opioid agonist EMD 61753 on pain and inflammation in rats and humans.
Machelska H; Pflüger M; Weber W; Piranvisseh-Völk M; Daubert JD; Dehaven R; Stein C
J Pharmacol Exp Ther; 1999 Jul; 290(1):354-61. PubMed ID: 10381799
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of mu-, delta-, and kappa-opioid receptor agonists on mechanosensitive gastric vagal afferent fibers in the rat.
Ozaki N; Sengupta JN; Gebhart GF
J Neurophysiol; 2000 Apr; 83(4):2209-16. PubMed ID: 10758129
[TBL] [Abstract][Full Text] [Related]
13. Use of receptor chimeras to identify small molecules with high affinity for the dynorphin A binding domain of the kappa opioid receptor.
Kumar V; Guo D; Marella M; Cassel JA; Dehaven RN; Daubert JD; Mansson E
Bioorg Med Chem Lett; 2008 Jun; 18(12):3667-71. PubMed ID: 18487043
[TBL] [Abstract][Full Text] [Related]
14. N-methylacetamide analog of salvinorin A: a highly potent and selective kappa-opioid receptor agonist with oral efficacy.
Béguin C; Potter DN; Dinieri JA; Munro TA; Richards MR; Paine TA; Berry L; Zhao Z; Roth BL; Xu W; Liu-Chen LY; Carlezon WA; Cohen BM
J Pharmacol Exp Ther; 2008 Jan; 324(1):188-95. PubMed ID: 17951511
[TBL] [Abstract][Full Text] [Related]
15. Central and peripheral actions of the novel kappa-opioid receptor agonist, EMD 60400.
Barber A; Bartoszyk GD; Greiner HE; Mauler F; Murray RD; Seyfried CA; Simon M; Gottschlich R; Harting J; Lues I
Br J Pharmacol; 1994 Mar; 111(3):843-51. PubMed ID: 8019761
[TBL] [Abstract][Full Text] [Related]
16. ICI 204448: a kappa-opioid agonist with limited access to the CNS.
Shaw JS; Carroll JA; Alcock P; Main BG
Br J Pharmacol; 1989 Apr; 96(4):986-92. PubMed ID: 2568146
[TBL] [Abstract][Full Text] [Related]
17. The effect of kappa-opioid receptor agonists on tetrodotoxin-resistant sodium channels in primary sensory neurons.
Su X; Castle NA; Antonio B; Roeloffs R; Thomas JB; Krafte DS; Chapman ML
Anesth Analg; 2009 Aug; 109(2):632-40. PubMed ID: 19608841
[TBL] [Abstract][Full Text] [Related]
18. Effects of peripherally restricted κ opioid receptor agonists on pain-related stimulation and depression of behavior in rats.
Negus SS; O'Connell R; Morrissey E; Cheng K; Rice KC
J Pharmacol Exp Ther; 2012 Mar; 340(3):501-9. PubMed ID: 22128346
[TBL] [Abstract][Full Text] [Related]
19. Conformationally restricted κ-opioid receptor agonists: Synthesis and pharmacological evaluation of diastereoisomeric and enantiomeric decahydroquinoxalines.
Molenveld P; Bouzanne des Mazery R; Sterk GJ; Storcken RP; Autar R; van Oss B; van der Haas RN; Fröhlich R; Schepmann D; Wünsch B; Soeberdt M
Bioorg Med Chem Lett; 2015 Nov; 25(22):5326-30. PubMed ID: 26411794
[TBL] [Abstract][Full Text] [Related]
20. Effects of intracolonic opioid receptor agonists on polymodal pelvic nerve afferent fibers in the rat.
Su X; Julia V; Gebhart GF
J Neurophysiol; 2000 Feb; 83(2):963-70. PubMed ID: 10669508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
